NasdaqGM - Nasdaq Real Time Price USD

IRADIMED CORPORATION (IRMD)

Compare
53.23
+1.15
+(2.21%)
At close: 4:00 PM EST
53.23
0.00
(0.00%)
After hours: 4:01 PM EST
Loading Chart for IRMD
DELL
  • Previous Close 52.08
  • Open 52.73
  • Bid 38.19 x 200
  • Ask 68.07 x 200
  • Day's Range 52.49 - 54.81
  • 52 Week Range 40.05 - 57.95
  • Volume 38,487
  • Avg. Volume 41,831
  • Market Cap (intraday) 674.605M
  • Beta (5Y Monthly) 0.80
  • PE Ratio (TTM) 36.46
  • EPS (TTM) 1.46
  • Earnings Date Feb 6, 2025 - Feb 10, 2025
  • Forward Dividend & Yield 0.60 (1.15%)
  • Ex-Dividend Date Nov 15, 2024
  • 1y Target Est 60.00

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

www.iradimed.com

148

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IRMD

View More

Performance Overview: IRMD

Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IRMD
13.22%
S&P 500
24.72%

1-Year Return

IRMD
26.96%
S&P 500
30.82%

3-Year Return

IRMD
46.82%
S&P 500
26.62%

5-Year Return

IRMD
144.65%
S&P 500
91.37%

Compare To: IRMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IRMD

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    660.03M

  • Enterprise Value

    608.58M

  • Trailing P/E

    35.67

  • Forward P/E

    30.30

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.32

  • Price/Book (mrq)

    7.91

  • Enterprise Value/Revenue

    8.53

  • Enterprise Value/EBITDA

    27.47

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.12%

  • Return on Assets (ttm)

    14.67%

  • Return on Equity (ttm)

    23.58%

  • Revenue (ttm)

    71.31M

  • Net Income Avi to Common (ttm)

    18.63M

  • Diluted EPS (ttm)

    1.46

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    51.72M

  • Total Debt/Equity (mrq)

    0.32%

  • Levered Free Cash Flow (ttm)

    13.14M

Research Analysis: IRMD

View More

Company Insights: IRMD

Research Reports: IRMD

View More

People Also Watch